Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 20 | 2024 | 1251 | 2.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 10 | 2025 | 826 | 1.110 |
Why?
|
| Hypoglycemic Agents | 13 | 2025 | 441 | 1.010 |
Why?
|
| Insulin Resistance | 5 | 2021 | 643 | 0.860 |
Why?
|
| Hypoglycemia | 5 | 2025 | 193 | 0.830 |
Why?
|
| Blood Glucose | 16 | 2025 | 1129 | 0.740 |
Why?
|
| Metformin | 4 | 2020 | 148 | 0.710 |
Why?
|
| Hyperglycemia | 4 | 2022 | 222 | 0.630 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 606 | 0.480 |
Why?
|
| Insulin | 7 | 2022 | 1207 | 0.440 |
Why?
|
| Adolescent | 25 | 2025 | 19303 | 0.370 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 631 | 0.280 |
Why?
|
| Medication Adherence | 3 | 2020 | 400 | 0.280 |
Why?
|
| Automobile Driving | 1 | 2025 | 28 | 0.230 |
Why?
|
| Peer Group | 1 | 2024 | 119 | 0.220 |
Why?
|
| Mentors | 1 | 2024 | 143 | 0.210 |
Why?
|
| Quality of Life | 3 | 2024 | 1947 | 0.200 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 120 | 0.200 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 274 | 0.190 |
Why?
|
| Puberty | 1 | 2021 | 95 | 0.180 |
Why?
|
| Sleep | 1 | 2024 | 341 | 0.180 |
Why?
|
| Self Report | 1 | 2024 | 520 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 102 | 0.180 |
Why?
|
| Humans | 33 | 2025 | 124502 | 0.170 |
Why?
|
| Child | 18 | 2022 | 24436 | 0.170 |
Why?
|
| Young Adult | 6 | 2025 | 8976 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 121 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 141 | 0.160 |
Why?
|
| Age of Onset | 1 | 2020 | 582 | 0.160 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 13 | 0.150 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2025 | 125 | 0.150 |
Why?
|
| Medicaid | 1 | 2020 | 243 | 0.150 |
Why?
|
| Self Care | 3 | 2024 | 214 | 0.140 |
Why?
|
| Male | 20 | 2025 | 61062 | 0.130 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 112 | 0.130 |
Why?
|
| Female | 21 | 2025 | 66333 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2020 | 4749 | 0.130 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 291 | 0.130 |
Why?
|
| Insulin Infusion Systems | 3 | 2022 | 66 | 0.130 |
Why?
|
| Glucagon | 1 | 2016 | 185 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 60 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2025 | 1401 | 0.120 |
Why?
|
| Biomarkers | 2 | 2024 | 2990 | 0.120 |
Why?
|
| Depression | 4 | 2016 | 1244 | 0.120 |
Why?
|
| Family | 2 | 2009 | 565 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 859 | 0.110 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2014 | 15 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 61 | 0.110 |
Why?
|
| Risk Factors | 6 | 2024 | 10182 | 0.110 |
Why?
|
| Adult | 7 | 2024 | 29407 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 779 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 332 | 0.090 |
Why?
|
| Heart Atria | 1 | 2014 | 317 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2021 | 1556 | 0.090 |
Why?
|
| Cysteine | 1 | 2010 | 135 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 167 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2023 | 436 | 0.080 |
Why?
|
| Glutathione | 1 | 2010 | 192 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 769 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 187 | 0.070 |
Why?
|
| Glucose | 2 | 2023 | 885 | 0.070 |
Why?
|
| Parents | 1 | 2015 | 1029 | 0.070 |
Why?
|
| Obesity | 3 | 2015 | 2266 | 0.070 |
Why?
|
| United States | 2 | 2020 | 10822 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2011 | 473 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2007 | 22 | 0.070 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 1913 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2009 | 245 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 48 | 0.070 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 50 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 54 | 0.070 |
Why?
|
| Health Promotion | 1 | 2007 | 392 | 0.060 |
Why?
|
| Health Behavior | 1 | 2007 | 385 | 0.050 |
Why?
|
| Social Support | 1 | 2005 | 347 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 11 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2024 | 198 | 0.050 |
Why?
|
| Accelerometry | 1 | 2022 | 60 | 0.050 |
Why?
|
| Exercise | 1 | 2007 | 816 | 0.050 |
Why?
|
| Time Factors | 2 | 2024 | 6285 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2898 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2022 | 14042 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 174 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1132 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5124 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6084 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 228 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 38 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 79 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 678 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 242 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2022 | 970 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 244 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 386 | 0.030 |
Why?
|
| Androgens | 1 | 2018 | 275 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 125 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 534 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 2441 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2015 | 5 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 410 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 436 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 186 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 491 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1158 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 25 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2014 | 26 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 107 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 872 | 0.030 |
Why?
|
| Testosterone | 1 | 2018 | 534 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 2028 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1688 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2041 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 2810 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2034 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16270 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 1004 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4572 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 23 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2010 | 70 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 27 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 41 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2010 | 183 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 119 | 0.020 |
Why?
|
| Prednisone | 1 | 2009 | 274 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 195 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 301 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2009 | 273 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1276 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 168 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 44 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 12322 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 26526 | 0.020 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 206 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 75 | 0.020 |
Why?
|
| Texas | 2 | 2007 | 3588 | 0.020 |
Why?
|
| Community Health Services | 1 | 2007 | 89 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 476 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2007 | 66 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 98 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 81 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1288 | 0.020 |
Why?
|
| Magnesium | 1 | 2006 | 121 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2009 | 384 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 52 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 226 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 259 | 0.020 |
Why?
|
| Health Education | 1 | 2007 | 222 | 0.020 |
Why?
|
| Minority Groups | 1 | 2007 | 251 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2007 | 447 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 397 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2006 | 264 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 827 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 984 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2003 | 50 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 19560 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2010 | 824 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 676 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 1126 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 191 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1096 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 847 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2006 | 814 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1662 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3066 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1892 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 3725 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 7170 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8181 | 0.010 |
Why?
|